Adverse Events During Chimeric Antigen Receptor T-cell (CAR-T) Therapy for Hematologic Malignancies (HM): Real-world, US Patient Experience
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined